ZYMUTEST™ HIA IgGAM — Pan-Isotype HIT Screening ELISA (IgG/IgA/IgM)
Processing...

ZYMUTEST™ HIA IgGAM — Pan-Isotype HIT Screening ELISA (IgG/IgA/IgM)

Code: ARK040D-CAN
Manufacturer’s Part Number: RK040D
Product size: Kit of 96 tests
Clearance: CE / HCL

Price: $956.00

Qty

Product Description

Pan-isotype ELISA for detection of heparin-PF4 antibodies of all isotypes (IgG, IgA, IgM) in plasma or serum. Maximum sensitivity HIT screening. CE-IVD / 510(k).

Detects all antibody isotypes responsible for HIT/HITT, including IgA/IgM-only cases that would be missed by IgG-specific assays. Positive results should be followed with ZYMUTEST™ HIA IgG (RK040A) for IgG-specific confirmation.

  • Pan-isotype (IgG + IgA + IgM) — maximum screening sensitivity
  • 96-test plate format, CE-IVD and 510(k)

Product Characteristics

  • Total Assay Time: 2 hr 15 min
  • Cut Off: A450 ≥ 0.50
  • Dynamic Range: A450 up to 3.0
  • Intra-Assay CV: 4 to 6%
  • Inter-Assay CV: 5 to 8%

Product Components

  • Micro ELISA Plate (12 strips of 8 wells)
  • 2x HIA Sample Diluent.
  • 3x HIA IgGAM Positive Control.
  • 3x Negative Control.
  • 3x Platelet Lysate.
  • 3x Anti-IgG (Fcγ)-IgM (µ)-IgA(α)-HRP IC
  • 1x Conjugate Diluent.
  • 1x Wash Solution.
  • 1x TMB.
  • 1 x 0.45M Sulfuric Acid.
  • Video of Product Components
    (Video can be viewed with Flash Plugin)

Product Applications

Assessment of the risk to develop HIT/HITT, in patients treated with heparins (Unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT.

Clinical suspicion of HIT during heparin therapy.

Instructions For Use

Data Sheet/Technical Data

Certificate of Analysis (COA)

Other Documents